Katalog der Deutschen Nationalbibliothek

Expertensuche ?

Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00

Wegen Wartungsarbeiten ist vom 12. bis 14. Januar 2026 der Museumslesesaal, sowie vom 14. bis 16. Januar 2026 der Musiklesesaal geschlossen. // Due to maintenance work the museum reading room will be closed from 12 to 14 January 2026 and the music reading room from 14 to 16 January 2026.

Ergebnis der Suche nach: "Originator"
im Bestand: Gesamter Bestand

11 - 20 von 138

	11	Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort study Fischer, Sarah. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2024
	12	Inpatient Infliximab Biosimilar Cost-Savings: Cost Analysis of Inpatient Treatment with Originator Infliximab (Remicade ™) versus Biosimilar Infliximab (Renflexis ™) for Acute Severe Ulcerative Colitis Enthalten in Digestive diseases Bd. 42, 2024, Nr. 5: 496-502. 6 S.
	13	The annual update GLODAPv2.2023: the global interior ocean biogeochemical data product Enthalten in Earth system science data Bd. 16, 2024, Nr. 4: 2047-2072. 26 S.
	14	Conjugation of Polycationic Peptides Extends the Efficacy Spectrum of β‐Lactam Antibiotics Enthalten in Advanced science 05.11.2024. 12 S.
	15	Real-World Comparative Analysis of Trastuzumab Originator and Biosimilars: Safety, Efficacy, and Cost Effectiveness Enthalten in BioDrugs 16.10.2024: 1-12
	16	Effectiveness and Safety Data in Rheumatoid Arthritis Patients after Switching from Originator Rituximab to Biosimilar Rituximab (CT-P10) Enthalten in Aktuelle Rheumatologie 01.10.2024
	17	Safety profile of trastuzumab originator vs biosimilars: a systematic review and meta-analysis of randomized clinical trials Enthalten in Clinical and translational oncology 18.9.2024: 1-13
	18	Clinical Utilization of Generic Drugs and Biosimilars for Ulcerative Colitis Treatment: Insights from a Nationwide Database Study in Japan Enthalten in Inflammatory intestinal diseases Bd. 9, 2024, Nr. 1: 29-39. 11 S.
	19	Switching from adalimumab originator to biosimilar in patients with hidradenitis suppurativa results in losses of response — data from the German HS registry HSBest Kirsten, Natalia. - Würzburg : Universität Würzburg, 2023
	20	In Defense of Disinformation Enthalten in Journal of homeland security and emergency management Bd. 21, 2023, Nr. 3: 441-466. 26 S.

11 - 20 von 138

Alle Materialarten

Alle Kataloge/Sammlungen

Alle Standorte > Leipzig (138)

Aktionen

Administration